Mr. Craig Leon reports

CORRECTION TO MYNDTEC INC. PRESS RELEASE ISSUED DECEMBER 3, 2025 REGARDING NON-BROKERED PRIVATE PLACEMENT

Myndtec Inc. today issued a correction to its news release, titled "MyndTec Inc. Completes Eighth Tranche of Non-Brokered Private Placement," issued on Dec. 3, 2025.

The initial news release incorrectly stated the number of units issued under the eighth tranche of the private placement offering as 351,475 units, the aggregate gross proceeds to the company as $70,295 and the aggregate units issued to date under the offering as 4,163,978 for aggregate gross proceeds of $832,824.60. The correct figures are 352,776 units issued under the eighth tranche for aggregate gross proceeds of $70,555, bringing the aggregate units issued to date under the offering to 4,165,279 for aggregate gross proceeds of $833,084.60.

This news release should be read in conjunction with the Initial Press Release. The correction described in this news release does not change any other information reported in the initial press release, including the issue price of 20 cents per unit, which remains unchanged. Each of the units, issue price, offering and eighth tranche are as defined in the initial news release.

About Myndtec Inc.

Myndtec is a Canadian Securities Exchange-listed medical technology company focused on using neurostimulation to restore function and improve treatment for individuals who have suffered from diseases, disorders and damage to the central nervous system, including Parkinson's disease, Alzheimer's disease and stroke. The company has developed the MyndMove system, a non-invasive functional electrical stimulation-based intervention, which uses neuroplasticity mechanisms to stimulate the development of new neural pathways allowing patients to re-establish voluntary movement and improve living independence. The company is researching new treatments and uses for neurostimulation and other technologies to improve patient outcomes.

We seek Safe Harbor.